Al-Khair Gadoon Explained: Foam Business and Earnings

Company Name: Al-Khair Gadoon Ltd

Ticker: AKGL

Al-Khair Gadoon is a small Pakistani manufacturer whose economics are easier to understand through chemistry and working capital than through the familiar image of a finished mattress. The company turns polyurethane inputs, textiles, springs and other components into foam, mattresses, sofa beds, furniture accessories and technical foam products. Its brand and product breadth help it reach several household price points, but imported raw materials, energy, inventory and short-term financing determine how much of each rupee of sales becomes cash and profit.

The recent results make that tension unusually clear. Revenue for the nine months ended March 31, 2026 edged up, yet gross profit, operating profit and net income fell sharply. The business therefore did not suffer primarily from an absence of sales; it suffered from weaker economics on those sales. For readers, the central questions are whether pricing can keep pace with input costs, whether inventory can convert into cash, and whether finance costs leave enough return for shareholders.

What the company does

The Pakistan Stock Exchange company profile says Al-Khair Gadoon was incorporated as a private company on August 27, 1990, converted into a public company on August 31, 1995, and principally manufactures and sells foam and allied products. The registered production address is in the Gadoon Amazai Industrial Estate in Swabi, Khyber Pakhtunkhwa. Its financial year ends in June.

The company’s own product catalogue broadens that description. It markets conventional foam and spring mattresses, orthopedic mattresses, sofa beds, furniture, pillows, cushions, bedsheets and several technical polyurethane products. The official shop and product page also lists compact or specialist formats such as SleepinBox, SofainBox, tri-fold and baby-cot mattresses, yoga mats, peeled foam and rebonded foam. This mix places the company between a consumer bedding brand and an industrial foam converter.

That distinction matters. A branded mattress can earn value from comfort design, presentation, trust and distribution, while peeled, rebonded or other technical foam is closer to an input for furniture, upholstery or industrial users. The product range can diversify demand, but the public disclosures reviewed do not provide revenue or margin by product. Readers should not assume that every product contributes equally.

History, footprint and scale

The company’s management history page traces the brand to 1980, commercial production at the Gadoon plant to October 9, 1990, the public-company transition to 1995, home textiles to 2008 and sofa beds to 2012. It also says the company acquired a fleet of 50 delivery vehicles in 2014. These dates are management’s account of the operating history; the current size and deployment of that fleet are not separately disclosed.

The company is modest in scale. It has 10 million ordinary shares and the official PSX profile reports a 10% free float. Business Recorder’s filing-based review says FY2025 production remained at 1,800 tons and the workforce declined from 190 to 165. Scale can help a focused manufacturer remain nimble, but it also means procurement, energy and finance shocks can be large relative to profit.

How the business model works

From chemical inputs to finished comfort products

The company does not publish a detailed production flow. AlphaGen’s process description is therefore an inference from the product set and standard flexible-polyurethane manufacturing. Polyols and isocyanates are combined with catalysts, additives and blowing agents to create foam. The foam is cured, cut or peeled, profiled and laminated. Mattress production then adds textiles, covers, adhesives and, for spring products, metal spring units before inspection, packaging and dispatch. Rebonded foam uses recovered foam pieces bound into a denser product.

Inputs, imports and energy

Business Recorder’s review of the FY2025 and nine-month FY2026 filings attributes the FY2025 rise in cost of sales to labour, energy and imported raw materials, and links higher finance cost to short-term borrowing for those imports. That is the core dependency. Chemical inputs priced directly or indirectly in foreign currency expose the company to the rupee even when the sale is domestic. Inventory must often be purchased before a finished mattress is sold, so currency and interest rates meet inside working capital.

Textiles, springs, adhesives, packaging, labour, freight and factory utilities add further cost. Public disclosures do not identify individual suppliers or the local-import split, so it would be unsafe to name counterparties or claim a precise import share. Economically, however, a weaker rupee, expensive credit, unreliable power or higher fuel costs all raise the cash needed to maintain the same level of production and distribution.

Customers, pricing and route to market

The likely customer groups are household buyers, furniture and bedding retailers, dealers, institutional buyers and manufacturers that use technical polyurethane products. This grouping is AlphaGen inference from the catalogue, not a disclosed customer list. The company does not publish named customers, geographic revenue splits or concentration metrics.

The route to market appears to combine branded retail and dealer distribution, direct digital discovery through the company website, and physical delivery. The historical fleet investment suggests management considered last-mile availability important. Mattresses are bulky relative to their value, so delivery density, dealer relationships, packaging and return handling can influence economics almost as much as advertising.

Pricing is a balancing act. In FY2025, filing-based analysis indicates sales growth came mainly from price revisions while production remained flat. That implies price rather than volume was the principal growth lever. Yet a manufacturer serving affordability-sensitive households cannot always pass through currency, chemical and energy inflation immediately. Competitors can delay price increases, while consumers can defer replacement or trade down. The result is often a lag: costs rise first, selling prices catch up later, and gross margin compresses in between.

The earnings engine: revenue, margin and cash

For FY2025, official PSX financial history reports sales of PKR 1.399 billion, up 9.43% from PKR 1.278 billion in FY2024. Profit after tax fell to PKR 17.145 million from PKR 27.253 million, and earnings per share declined to PKR 1.71 from PKR 2.73. Business Recorder calculates a FY2025 gross margin of about 12.4% and a net margin of only 1.23%. Revenue therefore increased, but most of the additional gross value was absorbed before reaching shareholders.

The nine months ended March 31, 2026 were weaker. The official nine-month report covers the exact period, while the PSX results transmission records the announced result. Filing-derived figures show sales of PKR 1.063 billion versus approximately PKR 1.046 billion in the comparable period, an increase of about 1.6%. Net income was only PKR 1.375 million versus PKR 16.75 million, and earnings per share fell to PKR 0.14 from PKR 1.67.

The third quarter alone illustrates the deterioration: sales were PKR 376.23 million compared with PKR 380.35 million, but the company moved to a PKR 7.30 million loss from a PKR 9.72 million profit. Business Recorder says the nine-month gross margin declined to roughly 11.0% from 12.55%, operating profit fell 34.7%, and other income dropped 71.9%. Lower finance cost offered some relief, but not enough to offset weaker core profitability and reduced non-operating support.

The economic reading is straightforward. Near-flat sales combined with cost of sales growing faster than revenue reduces the amount available for administration, selling expense, finance cost and tax. When net margin starts near 1%, a one-percentage-point movement in gross margin is not small—it can consume most of the profit. Other income can soften a difficult year, but it should not be treated as a substitute for durable manufacturing margin.

Key facts and figures

1. Founded: the company’s history traces the Al-Khair brand to 1980. Official company history

2. Corporate form: incorporated August 27, 1990 and converted into a public company August 31, 1995. PSX company profile

3. Operating site: Gadoon Amazai Industrial Estate, Swabi, Khyber Pakhtunkhwa. PSX company profile

4. Shares: 10 million ordinary shares; PSX reports a 10% free float. PSX company profile

5. FY2025 sales: PKR 1.399 billion, 9.43% above FY2024. PSX financial history

6. FY2025 profit after tax: PKR 17.145 million, down 37.1%; EPS PKR 1.71. PSX financial history

7. FY2025 production: 1,800 tons, unchanged according to a filing-based review. Business Recorder analysis

8. Nine-month FY2026 sales: PKR 1.063 billion, up about 1.6% year on year. Official March 2026 report

9. Nine-month FY2026 net income: PKR 1.375 million versus PKR 16.75 million; EPS PKR 0.14 versus PKR 1.67. Official March 2026 report

10. March 2026 balance sheet: inventory PKR 479.11 million, cash PKR 19.70 million and total debt PKR 369.46 million in a filing-derived standardized statement. StockAnalysis balance-sheet compilation

11. FY2025 operating cash flow: negative PKR 116.50 million, with inventory absorbing PKR 73.12 million of cash; net debt issuance was PKR 102.44 million. StockAnalysis cash-flow compilation

12. Workforce: 165 employees in FY2025, down from 190, according to a filing-based review. Business Recorder analysis

Balance sheet and cash conversion

For this company, profit and cash can diverge sharply. Filing-derived standardized data show March 2026 inventory of PKR 479.11 million—far larger than cash of PKR 19.70 million and equal to a substantial portion of total assets of PKR 781.18 million. Total debt was PKR 369.46 million, almost entirely short term. These figures should be checked against the underlying filing presentation, but they reveal the operating shape: capital sits in raw materials and finished goods while borrowings finance the gap.

FY2025 produced negative operating cash flow of PKR 116.50 million even though the income statement reported a profit. Inventory increased by PKR 73.12 million, other working-capital movements also consumed cash, and net borrowing supplied PKR 102.44 million. This does not automatically mean the inventory is impaired; it may include deliberate stocking of imported inputs or goods awaiting sale. But it does mean reported earnings did not convert into cash that year.

AlphaGen inference: the cash cycle is the company’s most important financial control point. If raw-material purchases rise ahead of demand, if finished goods move slowly, or if dealers take longer to pay, debt and finance cost can rise before revenue appears. Conversely, disciplined inventory reduction can release cash even in a slow sales period. Readers should therefore pair every income statement with inventory, trade receivables, payables, short-term borrowing and operating cash flow.

Competitive position and operating environments

Al-Khair’s apparent strengths are its long operating history, recognizable consumer positioning, breadth from entry-level foam to orthopedic and spring products, technical-foam capability, and an established manufacturing and distribution footprint. Management’s corporate briefing and product pages present this breadth as a quality-and-choice proposition. These are useful assets, but public data do not establish market share, pricing power or a structural cost lead.

A favourable environment would combine stable or stronger currency, lower short-term interest rates, reliable energy, improving household purchasing power and healthy housing or furniture demand. Under those conditions, input-cost pass-through becomes easier, inventory turns faster and finance cost falls. Product mix shifting toward higher-value mattresses or technical products could add support if the incremental margin exceeds additional selling and complexity costs.

An adverse environment is the reverse: rupee weakness, costly or scarce imported chemicals, high rates, energy disruption and weak discretionary demand. Aggressive discounting by competitors can make the problem worse. The company can preserve volume by holding price, but may sacrifice gross margin; it can protect margin by raising price, but may lose units. The nine-month FY2026 result demonstrates how quickly modest gross-margin pressure can reach the bottom line.

Growth avenues—and the evidence test

The existing catalogue offers several plausible growth paths: compressed delivery formats such as SleepinBox and SofainBox, orthopedic and spring products, accessories that increase each customer’s basket, technical polyurethane applications, stronger digital lead generation, and tighter dealer coverage. Operationally, better foam yield, scrap reuse, energy efficiency and inventory planning could matter as much as new revenue.

These are AlphaGen inferences from the current product set and cost structure, not disclosed forecasts. A credible growth claim should pass three tests: it should lift volume or mix without disproportionate discounting; it should improve gross profit after freight and selling expense; and it should not require so much inventory or borrowing that cash conversion deteriorates. Readers should look for evidence in production volume, gross margin, inventory days, operating cash flow and finance cost rather than relying on product launches alone.

How to read this company’s results

Start with sales growth, then ask whether it came from volume, price or mix. FY2025 is a useful example: reported sales rose while production remained flat, suggesting price carried the increase. Price-led growth can be healthy when it protects purchasing power, but it is less convincing if volume contracts or gross margin still falls.

Second, watch gross margin in basis points, not merely gross-profit rupees. With net margin around 1% in FY2025, a relatively small deterioration in production cost, discounts or yield can erase earnings. Third, separate operating profit from other income. A rebound driven by investment income or asset disposal is less repeatable than one driven by manufacturing margin.

Fourth, compare inventory growth with sales and production. Rising inventory can be strategic ahead of demand or import constraints, but persistent accumulation ties up cash and raises storage, obsolescence and borrowing risk. Fifth, compare finance cost and short-term debt with operating profit. If debt rises faster than gross profit, shareholders may receive little benefit from revenue growth.

Finally, reconcile profit to operating cash flow. Look at receivables, inventory, supplier credit, tax paid and capital expenditure. For Al-Khair Gadoon, this reconciliation is essential because FY2025 reported a profit while operating cash flow was negative. Also monitor any disclosure on product mix, capacity utilization, pricing, raw-material sourcing and energy efficiency; current public segment detail is limited.

Risks and what to monitor next

The principal risks are imported-input and currency exposure; volatile energy and freight costs; short-term borrowing and interest expense; inventory build-up; weak household demand; competitive discounting; thin operating and net margins; and limited public detail on product mix, customer concentration and supplier concentration. Chemical manufacturing and bulky-product logistics also create quality, safety, environmental and return-handling risks even though the reviewed disclosures do not quantify them.

The next indicators to monitor are quarterly sales volume and price mix, gross margin, production tonnage, inventory and receivable days, operating cash flow, short-term debt, finance cost, other income, capital expenditure and any evidence of sustained margin from newer formats or technical products. The most constructive signal would be a combination of stable sales, recovering gross margin and positive operating cash flow without another borrowing increase.